
Opinion|Podcasts|August 1, 2024
Optimizing Treatment Outcomes in Retinal Vein Occlusion
Listen
0:00 / 0:00
Key Takeaways
- Retinal vein occlusion requires strategic treatment selection and diagnostic approaches to address its complex challenges effectively.
- Angiopoietin-2 significantly impacts RVO progression and treatment outcomes, necessitating its consideration in management strategies.
A panel of ophthalmologists discuss strategies for improving patient outcomes in retinal vein occlusion with anti-VEGF and other therapies.
Advertisement
0:50 RVO Challenges
2:30 Treatment Selection
8:00 Diagnostics
10:50 Role of Ang-2 in RVO
13:50 Steroids in RVO
18:00 Patient Education
Advertisement
Latest CME
Advertisement
Advertisement
Trending on HCPLive
1
Tirzepatide Demonstrates Cardioprotective Effects in T2D With ASCVD
2
Phase 3 Dermatomyositis Trial Sees Brepocitinib Meet Primary Endpoint
3
Q&A: Fear, Not Appetite Loss, Drives ARFID Eating Patterns in Food Allergy
4
Omalizumab-Facilitated OIT Enables Maintenance Dosing in Food Allergy
5








































































